Navigation Links
Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital Infections
Date:3/18/2008

NEW YORK, March 18 /PRNewswire-USNewswire/ -- A new study in the Annals of Internal Medicine adds weight to the growing evidence that screening incoming hospital patients for the bacterium MRSA (methicillin-resistant Staphylococcus aureus) is effective, and indeed essential, to reduce MRSA hospital infections. The study, published yesterday, resulted in a 70% reduction in MRSA hospital infections at the three hospitals in the Evanston Northwestern Healthcare System, located near Chicago.

This was the first "large scale, universal admission MRSA surveillance program in the United States," researchers reported, but the stunning results are consistent with at least fifty earlier studies showing that it is not possible to stop the spread of drug-resistant bacteria from patient to patient without screening. "To stop MRSA from racing through the hospital, you must know the source, that is, which patients are bringing it in," says Betsy McCaughey, Ph.D., Chairman of the Committee to Reduce Infection Deaths. "Without screening, the germs spread rapidly on equipment, lab coats, blood pressure cuffs, wheel chairs, virtually every surface. Patients who are carrying MRSA unknowingly shed it everywhere, putting the patients around them at risk."

Evanston-Northwestern researchers used a rapid test (average turnaround time from swabbing the patient to receiving test results at bedside was 18 hours). The rapid test enabled caregivers to promptly isolate patients identified as MRSA positive, use gowns, gloves and dedicated or disposable equipment when treating them, and apply mupirocin to their nasal passages and chlorhexidine to their skin to reduce the presence of the bacteria.

"This new study sets the record straight, correcting the misimpression created by an article in the Journal of the American Medical Association on March 12th suggesting that screening for MRSA was ineffective. That previous study, done in one surgical ward of a Geneva Switz
'/>"/>

SOURCE Committee to Reduce Infection Deaths
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems Assurance Pharmaceutical Care System(TM)
2. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
3. Neighborhoods play key role in how much people exercise, study says
4. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
5. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
6. Study Finds Potential Cause of Age-Related Macular Degeneration
7. New Study: Pycnogenol(R) Improves Memory in Elderly
8. Researchers study new drug and indications for heated chemotherapy treatment
9. Scripps research team wins $4M grant to study effects of chronic marijuana use
10. Meditation impacts blood pressure, study shows
11. Mayo Clinic study shows Parkinsons disease drug might work in cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)...te (TM) has been shown in studies to be effective ...ed by an overload of copper, and certain metastati...r, is known about how the drug works at the molecu...versity researchers now has provided an invaluable... to copper-loaded metallochaperones. The drug sequ...
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...wswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. ...will host two investor events in December: ,, ....m. CT/10:00 a.m. ET ,, Principal investigato...filzomib in relapsed and/or refractory multiple my... Hematology (ASH) Annual Meeting and Exposition in...
(Date:11/25/2009)...USNewswire/ -- The Black AIDS Institute recently h...tive leadership for 2010. ,, The new Board Memb...cialties in public policy, law, finance, governmen...eneurship. The Board also comes from a wide range ...l and gay Black men and women, some living with HI...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...tes for the Achievement,of Human Potential (IAHP) ...dren from five continents will converge on The Ins...nia on December 1, 2008 to attend "What,To Do Abou...d who is almost normal but not quite., There are ...
...LORIDA NOVEMBER 20, 2008, JUPITER, Fla., Nov. 3 ...glund will be in the Sunshine State to promote,Nat...er new cause of,helping Americans get healthier an... TO PROMOTE SAVING LIVES, AND URGING SMOKERS ...
...Mass., Nov. 3 Psychemedics Corporation,(Nasdaq: ...lts for the,period ended September 30, 2008. The C...7 per share payable to shareholders of record as o...nue was $6.2 million, down 4% as,compared to $6.5 ...
...evious poll, Democratic contender,still enjoys bro...ning days of the,2008 Presidential Campaign, healt...ll.) over Sen. John McCain (R-Ariz.) by a sizable ...81103/NY43443 ), Asked to choose which candidate...
...s, updated guidance, and new stock ...ICAS, Inc. (Nasdaq: AMCS ), a,leader in radiology...tions,today reported unaudited financial results f...enue: Total revenues for the third quarter of 2008...
...ted by researchers at Georgia State University is ...ration of preemptive morphine prior to a painful p...consequences of pain in adult rodents. These stud...e preemptive pain medication prior to surgery were...
Other Medicine News:Health News:Parenting Course at The Institutes for the Achievement of Human Potential Gives Parents the Tools to Help their Special Needs Kids Have a Fighting Chance 2Health News:Psychemedics Corporation Announces Third Quarter Results 2Health News:Psychemedics Corporation Announces Third Quarter Results 3Health News:Psychemedics Corporation Announces Third Quarter Results 4Health News:Psychemedics Corporation Announces Third Quarter Results 5Health News:Election-Eve MedPage Today(R) Poll Gives Obama Double-Digit Lead Among Clinicians 2Health News:Election-Eve MedPage Today(R) Poll Gives Obama Double-Digit Lead Among Clinicians 3Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 2Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 3Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 4Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 5Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 6Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 7Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 8Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 9Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 10Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 11Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 12Health News:GSU study first to confirm long-term benefits of morphine treatment in infants 2
(Date:11/25/2009)...RNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABA...t-of-care blood analysis systems, announced today ...officer, will present at the 21st Annual Piper Jaf... 2, 2009 at 2:00 p.m. ET. The conference will be h... ,, About Abaxis ,, Abaxis develops, manu...
(Date:11/25/2009)...RNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: N...ing products for minimally disruptive surgical tre...l host a conference call on Monday, November 30, 2...ce call will focus on current issues relative to r...nclude comments from management followed by a shor...
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...very-USMarketTrends&Analysis http://www.repor...-Market-Trends--Analysis.html ,, TheUSintranas...peuticapplicationsfromthedeliveryofconventionalloc...icdrugs.Thefutureofthetechnologyhingesontotheeffec...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5University of Louisville neuroscientists hope to get people walking again 58667 1Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 1Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 2Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 3Experts gather at McGill University to address food security challenges 10216 1
...m, January 19 , - New Funds to Drive Clinical...l-Based Therapy for Heart Failure , Cardio3 Bi... specialising,in cell-based therapies for the trea...2 million in a successful Series B fund raising ro...f new and existing investors, will be,used to fina...
...rin Co., Ltd. (Chiyoda-ku, Tokyo Japan; President,...o Time) that it has decided to continue the domest... disease drug KW-6002 (generic name: Istradefyllin...al in Japan. , , KW-6002 has a novel mechanism of...e A2A receptor. Kyowa Hakko Kirin initiated the cl...
Other Medicine Technology:Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 2Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 3Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 4Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 5Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinson's Disease Drug KW-6002 (Istradefylline) 2
... LD400 FT is an affordable full-field, autoperimet...g exam time by at least 40%. It has a small footpr...rapid setup and easy two-button operation making i...endly. The LD 400 FT is the workhorse of the Parad...
...Clear Corneal Diamond Knife is a unique design dev...anta Maria, California. This special knife was cre...rument that could be used in performing his Clear ...ollaboration between KOI and Dr. Shepard, this kni...
...g ClosureWire Vascular Closure System (VCS) utiliz...c Compression., ,The Boomerang ClosureWire tec... the inside of the arteriotomy and just outside th...ompression of both the arteriotomy and tract. The ...
EndoProbe Handpieces
Medicine Products: